Aino Health AB (OSTO:AINO) EBIT: kr-6.85 Mil (TTM As of Mar. 2026)


OSTO:AINO Aino Health AB OSTO:AINO
26 GF Score
Price kr0.13
GF Value kr0.13
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aino Health AB EBIT?

Aino Health AB OSTO:AINO 26 EBIT is kr-6.85 Mil as of Mar. 2026. GuruFocus rates OSTO:AINO with a GF Score™ of 26/100 and a GF Value™ of kr0.13 (Fairly Valued). The stock has 4 warning signs investors should review.

Aino Health AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was kr-2.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-6.85 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aino Health AB's annualized ROC % for the quarter that ended in Mar. 2026 was -87.10%. Aino Health AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -15,260.38%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aino Health AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -23.87%.


Aino Health AB  (OSTO:AINO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aino Health AB's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-8.088 * ( 1 - 0% )/( (8.276 + 10.295)/ 2 )
=-8.088/9.2855
=-87.10 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Aino Health AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-8.088/( ( (0.054 + max(-6.632, 0)) + (0.052 + max(-8.761, 0)) )/ 2 )
=-8.088/( ( 0.054 + 0.052 )/ 2 )
=-8.088/0.053
=-15,260.38 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.107 + 0 + 0.08) - (2.322 + 0 + 5.497)
=-6.632

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + -8.8817841970013E-16) - (0 + 0 + 8.761)
=-8.761

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aino Health AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-6.852/28.702
=-23.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aino Health AB EBIT Related Terms


Aino Health AB EBIT Historical Data

* Premium members only.

The historical data trend for Aino Health AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aino Health AB EBIT Chart

Aino Health AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.92 -14.17 -9.59 -9.14 -5.30

Aino Health AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -0.34 -1.03 -3.46 -2.02

OSTO:AINO vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, Aino Health AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aino Health AB EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aino Health AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aino Health AB's EV-to-EBIT falls into.


OSTO:AINO
26GF Score
Aino Health AB OSTO:AINO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aino Health AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-6.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr-6.85 Mil mean?
Aino Health AB (OSTO:AINO) has a EBIT of kr-6.85 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aino Health AB.
Is Aino Health AB's EBIT too high?
Aino Health AB's current EBIT is kr-6.85 Mil. Overall, Aino Health AB has a GF Score™ of 26/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's EBIT compare to VEEV and BTSG?
Aino Health AB's EBIT of kr-6.85 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aino Health AB. Aino Health AB's current EBIT is kr-6.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Based on GuruFocus' analysis, Aino Health AB (OSTO:AINO) is currently considered Fairly Valued. The stock's GF Value™ is kr0.13, compared to a current price of kr0.13 — trading 1.5% below its estimated fair value. The current EBIT is kr-6.85 Mil. Aino Health AB's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Aino Health AB (OSTO:AINO), the current EBIT is kr-6.85 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aino Health AB (OSTO:AINO) Overvalued in 2026?

Based on GuruFocus' analysis, Aino Health AB stock appears to be undervalued. The current stock price of kr0.13 is trading 1.5% below its estimated GF Value™ of kr0.13. GuruFocus considers Aino Health AB to be Fairly Valued.

Key valuation signals for OSTO:AINO:

  • EBIT: kr-6.85 Mil
  • GF Value™: kr0.13 vs. price of kr0.13 (1.5% below fair value)
  • GF Score™: 26/100 with 4 warning signs

No single metric tells the full story. See the OSTO:AINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aino Health AB Business Description

Other Exchanges 50V:Germany
Address c/o Hermelin & Friends, Kungsgatan 32, Stockholm, SWE, 111 35
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
26GF Score

Get the complete analysis for OSTO:AINO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.13
Price
kr0.13
GF Value